BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 32319000)

  • 1. Management of Chronic Immune Thrombocytopenia and Presumed Autoimmune Hepatitis in a Child with IKAROS Haploinsufficiency.
    Groth DJ; Lakkaraja MM; Ferreira JO; Feuille EJ; Bassetti JA; Kaicker SM
    J Clin Immunol; 2020 May; 40(4):653-657. PubMed ID: 32319000
    [No Abstract]   [Full Text] [Related]  

  • 2. Autoimmune Hepatitis Associated with Immune Thrombocytopenic Purpura.
    Ito A; Yoshizawa K; Fujimori K; Morita S; Shigeno T; Maejima T
    Intern Med; 2017; 56(2):143-147. PubMed ID: 28090042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A rare case of autoimmune hepatitis overlapping with autoimmune haemolytic anaemia and immune thrombocytopenic purpura in a male patient.
    Shanthi P; Sridhar R
    Med J Malaysia; 2012 Jun; 67(3):326-8. PubMed ID: 23082427
    [No Abstract]   [Full Text] [Related]  

  • 4. Unusual phenotype of heterozygous LOF mutation in IKZF1, with common variable immunodeficiency presenting initially as immune thrombocytopenia: A case report.
    Alzahrani TS; Al-Jabri H; Elhomoudi A
    J Paediatr Child Health; 2022 Dec; 58(12):2308-2311. PubMed ID: 35979904
    [No Abstract]   [Full Text] [Related]  

  • 5. Post-Partum Thrombotic Thrombocytopenic Purpura (TTP) in a Patient with known Idiopathic (Immune) Thrombocytopenic Purpura: a case report and review of the literature.
    Al-Husban N; Al-Kuran O
    J Med Case Rep; 2018 Jun; 12(1):147. PubMed ID: 29855343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Giant cell hepatitis and immune thrombocytopenic purpura: reversal of liver failure with rituximab therapy.
    Shores D; Kobak G; Pegram LD; Whitington PF; Shneider BL
    J Pediatr Gastroenterol Nutr; 2012 Oct; 55(4):e128-30. PubMed ID: 21921813
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of Children with Persistent and Chronic Idiopathic Thrombocytopenic Purpura: 4 Infusions of Rituximab and Three 4-Day Cycles of Dexamethasone.
    Oved JH; Lee CSY; Bussel JB
    J Pediatr; 2017 Dec; 191():225-231. PubMed ID: 29173312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Current topics in primary immune thrombocytopenia].
    Tomiyama Y
    Rinsho Ketsueki; 2017; 58(5):537-541. PubMed ID: 28592772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Rare Etiology of Severe Thrombocytopenia in Patient with Chronic Liver Disease.
    Ansari MZ; Tolstoy R; Jagadeeswaran G
    J Assoc Physicians India; 2018 Mar; 66(3):86-7. PubMed ID: 30341879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment of autoimmune hepatitis and idiopathic thrombocytopenic purpura with the monoclonal antibody, rituximab: case report and review of literature.
    Santos ES; Arosemena LR; Raez LE; O'Brien C; Regev A
    Liver Int; 2006 Jun; 26(5):625-9. PubMed ID: 16762009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Rituximab for treatment of immune thrombocytopenia and thrombotic thrombocytopenic purpura].
    Miyakawa Y
    Rinsho Ketsueki; 2019; 60(5):480-487. PubMed ID: 31168017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of refractory immune thrombocytopenia with rituximab in a 10-week-old infant.
    Gray C; Kalumba K; Pati N; Peterson A; Connell TG
    J Pediatr Hematol Oncol; 2013 May; 35(4):e174-7. PubMed ID: 23459375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel IKAROS haploinsufficiency kindred with unexpectedly late and variable B-cell maturation defects.
    Bogaert DJ; Kuehn HS; Bonroy C; Calvo KR; Dehoorne J; Vanlander AV; De Bruyne M; Cytlak U; Bigley V; De Baets F; De Baere E; Rosenzweig SD; Haerynck F; Dullaers M
    J Allergy Clin Immunol; 2018 Jan; 141(1):432-435.e7. PubMed ID: 28927821
    [No Abstract]   [Full Text] [Related]  

  • 14. Immune disease expressed in liver and platelets in an adolescent: a case report.
    Antunes H; Rocha R; Silva N; Pontes T; Antunes A; Martins S
    Ital J Pediatr; 2010 Jun; 36():42. PubMed ID: 20540743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment with the monoclonal antibody rituximab in two children with refractory autoimmune thrombocytopenia.
    Pusiol A; Cesaro S; Nocerino A; Picco G; Zanesco L; Bisogno G
    Eur J Pediatr; 2004 Jun; 163(6):305-7. PubMed ID: 15346911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rituximab in the treatment of immune thrombocytopenia: what is the role of this agent in 2019?
    Lucchini E; Zaja F; Bussel J
    Haematologica; 2019 Jun; 104(6):1124-1135. PubMed ID: 31126963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome concomitant with systemic sclerosis, immune thrombocytopenic purpura.
    Toyoda M; Yokomori H; Kaneko F; Yoshida H; Hoshi K; Takeuchi H; Tahara K; Takahashi A; Kudo T; Motoori T; Ohbu M; Kondo H; Hibi T
    Intern Med; 2009; 48(23):2019-23. PubMed ID: 19952485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of a single dose of rituximab in chronic immune thrombocytopenic purpura in childhood.
    Taube T; Schmid H; Reinhard H; von Stackelberg A; Overberg US
    Haematologica; 2005 Feb; 90(2):281-3. PubMed ID: 15710595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Primary Biliary Cirrhosis-autoimmune Hepatitis Overlap Syndrome with Immune Thrombocytopenia and Graves' Disease.
    Koyamada R; Higuchi T; Kitada A; Nakagawa T; Ikeya T; Okada S; Fujita Y
    Intern Med; 2015; 54(16):2013-6. PubMed ID: 26278293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B-cell-activating factor, a proliferation inducing ligand and co-stimulatory molecules in the pathogenesis of immune thrombocytopenia in childhood.
    Gözmen S; Karapnar TH; Tüfekçi Ö; Vergin C; Yüksel F; İrken G; Ören H
    Blood Coagul Fibrinolysis; 2016 Jul; 27(5):494-9. PubMed ID: 24911453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.